Concepedia

Hacı Arak

HA

Statistics

Publications

3

Citations

49

H-Index

3

Active since

2022

Affiliations

Antalya Eğitim ve Araştırma Hastanesi(Current)

Gaziantep University

Memorial Ankara Hospital

Dicle University

Okmeydanı Eğitim ve Araştırma Hastanesi

Hacı Arak is an author at Antalya Eğitim ve Araştırma Hastanesi specializing in metastatic disease treatment, oncology, and biochemical response assessment.

ORCID

Publications per year

2022–2023

3

Publications

3

The real‐world outcomes of Lutetium‐177 PSMA‐617 radioligand therapy in metastatic castration‐resistant prostate cancer: Turkish Oncology Group multicenter study

Elvina Almuradova, Mustafa Seyyar, Hacı Arak et al. · International Journal of Cancer · 2023 · 27 citations · Full text

, , +17

Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group

Çağlar Ünal, Abdulmunir Azizy, Senem Karabulut et al. · The Oncologist · 2023 · 12 citations · Full text

, , +17

Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer

Yusuf İlhan, Ali Murat Tatlı, Fatih Teker et al. · International Journal of Gynecological Cancer · 2022 · 10 citations

, , +13

1–3 of 3